Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
Asset disposition
Appointed director

CORCEPT THERAPEUTICS INC (CORT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2023 4 Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 2,418 shares @ $27.2493, valued at $65.9k
Exercised 2,418 options to buy @ $11.35, valued at $27.4k
10/04/2023 4 Swisher Daniel N JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 2,200 shares @ $27.32, valued at $60.1k
Exercised 2,200 options to buy @ $5.86, valued at $12.9k
10/04/2023 4 Maduck Sean (See Remarks) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 3,031 shares @ $27.2441, valued at $82.6k
Exercised 3,031 options to buy @ $3.02, valued at $9.2k
08/22/2023 4 Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 4,588 shares @ $31.19, valued at $143.1k
Exercised 3,755 options to buy @ $8.27, valued at $31.1k
Exercised 833 options to buy @ $11.35, valued at $9.5k
08/16/2023 4 MAHONEY DAVID L (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 10,000 shares @ $30.9467, valued at $309.5k
Sold 15,000 shares @ $30.9467, valued at $464.2k
08/15/2023 4 Hunt Hazel (Chief Scientific Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 20,455 shares @ $30.885, valued at $631.8k
08/09/2023 4 Hunt Hazel (Chief Scientific Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Paid exercise price by delivering 29,545 shares @ $30.48, valued at $900.5k
Exercised 50,000 options to buy @ $3.02, valued at $151k
08/09/2023 4 Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 412 shares @ $31.22, valued at $12.9k
Exercised 412 options to buy @ $8.27, valued at $3.4k
08/09/2023 4 Swisher Daniel N JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 2,200 shares @ $30.14, valued at $66.3k
Sold 650 shares @ $30.155, valued at $19.6k
Exercised 2,200 options to buy @ $6.55, valued at $14.4k
Exercised 650 options to buy @ $5.86, valued at $3.8k
07/19/2023 4 Maduck Sean (See Remarks) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Exercised 10,000 options to buy @ $1.92, valued at $19.2k
07/18/2023 4 BAKER G LEONARD JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
06/16/2023 4 Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Gifted 600 shares @ $0
06/12/2023 4 Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Gifted 725 shares @ $0
Gifted 650 shares @ $0
Gifted 725 shares @ $0
06/07/2023 4 Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 10,000 shares @ $23.6, valued at $236k
Exercised 10,000 options to buy @ $11.35, valued at $113.5k
06/05/2023 4 Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 2,091 shares @ $22.97, valued at $48k
Granted 2,091 shares @ $0
06/05/2023 4 Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 1,411 shares @ $22.97, valued at $32.4k
Granted 1,411 shares @ $0
06/05/2023 4 Mokari Atabak (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 1,651 shares @ $22.97, valued at $37.9k
Granted 1,651 shares @ $0
06/05/2023 4 Maduck Sean (See Remarks) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 1,658 shares @ $22.97, valued at $38.1k
Granted 1,658 shares @ $0
05/23/2023 4 BAKER G LEONARD JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 30,000 options to buy @ $24.1, valued at $723k
05/23/2023 4 Alton Gregg H (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 30,000 options to buy @ $24.1, valued at $723k
05/23/2023 4 Park Kimberly (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 30,000 options to buy @ $24.1, valued at $723k
05/23/2023 4 Swisher Daniel N JR (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 30,000 options to buy @ $24.1, valued at $723k
05/23/2023 4 WILSON JAMES N (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 80,000 options to buy @ $24.1, valued at $1.9M
05/23/2023 4 MAHONEY DAVID L (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 30,000 options to buy @ $24.1, valued at $723k
05/23/2023 4 Cannon Gillian (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 30,000 options to buy @ $24.1, valued at $723k
05/23/2023 4 Murray Joshua M. (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Granted 30,000 options to buy @ $24.1, valued at $723k
05/11/2023 4 Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Sold 30,000 shares @ $23.87, valued at $716.1k
Sold 14,000 shares @ $24.07, valued at $337k
05/09/2023 4 Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Paid exercise price by delivering 60,586 shares @ $24.07, valued at $1.5M
Exercised 45,000 options to buy @ $1.92, valued at $86.4k
Exercised 60,000 options to buy @ $3.29, valued at $197.4k
05/09/2023 4 MAHONEY DAVID L (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC
Txns: Exercised 30,000 shares @ $1.74, valued at $52.2k
Paid exercise price by delivering 2,197 shares @ $23.76, valued at $52.2k
Exercised 30,000 options to buy @ $1.74, valued at $52.2k
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy